1LLY:BIT
Eli Lilly And Co
€1,040.00
arrow_downward
-0.44%(-4.60) 1D
Sep 29, 3:47:41 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1LLY...
Open
€1,047.20
High
€1,050.60
Low
€1,040.00
Mkt. cap
1.11T
Avg. vol.
346.00
Volume
206.00
52-wk high
€1,106.80
52-wk low
€610.00
No. of employees
50K
Open
€1,047.20
High
€1,050.60
Low
€1,040.00
Mkt. cap
1.11T
Avg. vol.
346.00
Volume
206.00
52-wk high
€1,106.80
52-wk low
€610.00
No. of employees
50K
News stories
From web sources and news partners
Benzinga
·
1 hour ago
Eli Lilly Launches Global Push to Expand Weight-Loss and Diabetes Drug Access in Lower Income Countries
Kalkine Media
·
1 hour ago
Is Eli Lilly (NYSE:LLY) the Healthcare Stocks Stock Everyone's Talking About Today?
Stock Titan
·
3 hours ago
An indirect comparison found over 3 times the odds of losing 20% of body weight on Lilly's drug versus Wegovy
MedWatch
·
3 hours ago
Eli Lilly targets larger deals to build business beyond obesity drugs
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Co
CEODavid A. Ricks
Employees50K
Founded1876
HeadquartersIndianapolis, Indiana, United States
SectorPharmaceutical industry
Websitelilly.com